Shuttle Pharmaceuticals Holdings (SHPH) Change in Cash (2021 - 2026)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Change in Cash came in at $755941.0 in Q1 2026, down 70.84% year-on-year from $2.6 million in Q1 2025, and up 142.94% quarter-over-quarter from -$1.8 million in Q4 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Change in Cash (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Change in Cash history runs 6 years deep, the most recent figure standing at $755941.0 for Q1 2026.
- On a quarterly basis, Change in Cash fell 70.84% year-over-year to $755941.0 in Q1 2026; TTM through Mar 2026 was -$3.4 million, a 209.91% decrease from a year earlier, with the FY2025 full-year figure at -$1.6 million, down 141.69% from the prior year.
- Change in Cash improved to $755941.0 in Q1 2026 per SHPH's latest filing, from -$1.8 million in the prior quarter.
- Across five years, Change in Cash topped out at $9.1 million in Q3 2022 and bottomed at -$2.7 million in Q3 2025.
- The 5-year median for Change in Cash is -$703034.0 (2024), against an average of $34423.4.
- Across the five-year window, Change in Cash tumbled 1161.92% in 2023 and soared 320.11% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$703187.0 in 2022, then tumbled by 86.24% to -$1.3 million in 2023, then surged by 234.66% to $1.8 million in 2024, then tumbled by 199.84% to -$1.8 million in 2025, then surged by 142.94% to $755941.0 in 2026.
- Per Business Quant, the three latest SHPH Change in Cash figures stand at $755941.0 (Q1 2026), -$1.8 million (Q4 2025), and -$2.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -277.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | 755,941.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 755,941.00 |
| Dec 31, 2025 | -1.76 Mn |
| Sep 30, 2025 | -2.72 Mn |
| Jun 30, 2025 | 305,065.00 |
| Mar 31, 2025 | 2.59 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | -538,938.00 |
| Jun 30, 2024 | -703,034.00 |
| Mar 31, 2024 | -1.18 Mn |
| Dec 31, 2023 | -1.31 Mn |
| Sep 30, 2023 | -1.56 Mn |
| Jun 30, 2023 | -1.72 Mn |
| Mar 31, 2023 | -1.25 Mn |
| Dec 31, 2022 | -703,187.00 |
| Sep 30, 2022 | 9.07 Mn |
| Jun 30, 2022 | -355,420.00 |
| Mar 31, 2022 | -98,892.00 |
| Dec 31, 2021 | 359,774.00 |